Eye drops for dry eye caused by meibomian gland dysfunction
Part of Eyes & vision clinical trials.
This trial tests eye drops made from a substance called perfluorohexyloctane, which may help reduce dry eye symptoms in people with meibomian gland dysfunction. It aims to see if the drops are safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have been diagnosed with dry eye disease related to meibomian gland dysfunction.
- You are willing to sign a consent form to participate.
- You have not used perfluorohexyloctane eye drops in the last 2 weeks.
- You have not participated in another clinical trial in the past month.
- You do not have allergies to any of the trial's ingredients, like fluorescein.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different dry-eye eye drops to see which works better and is safe. You may be able to join if you’ve had dry eye for at least 3 months and meet specific eye-test results.
This trial studies whether BUFY01 eye drops work better than SVS20 for treating dry eye disease. You may be able to join if you have dry eye symptoms for at least 3 months and meet eye exam score and tear-test requirements.
This study tests whether a new eye drop works as well as two other eye drops for people with moderate to severe dry eye caused by meibomian gland issues. If you qualify, you'll use one of the three drops and have your eye health checked over time.
This trial tests a food supplement designed to improve dry eye symptoms by targeting the microbiome. It may help if you have dry eye due to meibomian gland problems and are not using contact lenses or certain other eye treatments.
This trial tests a special eyelid massage device to see if it helps people with dry eye caused by blocked oil glands in the eyelids. It may improve symptoms and eye comfort.
This study tests a treatment called TearCare for young adults with a common type of dry eye caused by blocked oil glands in the eyelids. TearCare uses gentle heat to help unblock those glands and improve eye comfort.
Hear when a new Dry Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.